RadNet to acquire iCAD for $103M to advance AI-powered breast cancer detection worldwide
- bancheta6
- 6 minutes ago
- 1 min read
Los Angeles, CA and Nashua, NH, April 15, 2025 (Globe Newswire) -- RadNet will acquire iCAD for approximately $103 million in an all-stock deal to enhance its AI-powered breast cancer screening capabilities. iCAD’s integration into DeepHealth will expand RadNet’s global reach and accelerate its growth in diagnostic imaging. The acquisition brings together complementary technologies and teams to drive innovation in early cancer detection.
Read full article here.